Local lymphatic circulation disorder: A key promoter of tissue inflammation and organ fibrosis

Life Sciences · Published 2026-07-06 · DOI 10.1016/j.lfs.2026.124575

Authors (2)

Xun Wu, Chunjun Liu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wu, X., Liu, C. (2026). Local lymphatic circulation disorder: A key promoter of tissue inflammation and organ fibrosis. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124575

Related articles

• RPS20 phosphorylation acts as a molecular switch to integrate inflammatory and oxidative stress signals in sepsis · Life Sciences · 2026 · Same journal
• Identification of JEV capsid interacting domain(s) with host protein(s): Novel target for developing anti-JEV therapeutics · Life Sciences · 2026 · Same journal
• Ascorbic acid attenuates obesity induced myogenic impairment in C2C12 cells · Life Sciences · 2026 · Same journal
• Overactivated bradykinin–B2 receptor promotes type a aortic dissection by inducing endothelial dysfunction: Therapeutic effect of icatibant · Life Sciences · 2026 · Same journal
• Slc26a9 guards gastric mucosa against portal hypertension by reducing ER stress-induced apoptosis · Life Sciences · 2026 · Same journal
• The next-generation virtual cell: From spatiotemporal transcriptomic modeling to closed-loop target discovery in complex diseases · Life Sciences · 2026 · Same journal
• Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy · Life Sciences · 2026 · Same journal
• CCL28 ameliorates chronic liver damage associated with the recruitment of immunosuppressive IgA antibody-secreting cells in mice · Life Sciences · 2026 · Same journal
• Mertk-dependent immune regulation is required for the therapeutic effects of fecal microbiota transplantation in a mouse model of constipation-predominant irritable bowel syndrome · Life Sciences · 2026 · Same journal
• Patient-derived cornea organoids as drug repurposing models for aniridia-associated keratopathy · Life Sciences · 2026 · Same journal